Cargando…

Associations of multiple serum biomarkers and the risk of cardiovascular disease in China

BACKGROUND: Previous studies focus on one or several serum biomarkers and the risk of cardiovascular disease (CVD). This study aims to investigate the association of multiple serum biomarkers and the risk of CVD and evaluate the dose-relationship between a single serum metabolite and CVD. METHODS: O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Huichen, Hou, Chenyang, Liu, Weihua, Yi, Jihu, Su, Wencong, Hou, Qingzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523396/ https://www.ncbi.nlm.nih.gov/pubmed/32993518 http://dx.doi.org/10.1186/s12872-020-01696-7

Ejemplares similares

Associations of sleep quality and exercise frequency and the risk of coronary heart disease in Chinese urban elderly: a secondary analysis of cross-sectional data
por: Lin, Jiujing, et al.
Publicado: (2023)

Serum iron status and the risk of breast cancer in the European population: a two-sample Mendelian randomisation study
por: Hou, Chenyang, et al.
Publicado: (2021)

Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease
por: Forné, Carles, et al.
Publicado: (2019)

Associations of Serum Uric Acid with Clustering of Cardiovascular Risk Factors and a 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Jiangsu Adults, China
por: Tian, Ting, et al.
Publicado: (2021)

Association of Normal Serum Uric Acid Level and Cardiovascular Disease in People Without Risk Factors for Cardiac Diseases in China
por: Tian, Xue, et al.
Publicado: (2023)

Serum Level of Lactate Dehydrogenase is Associated with Cardiovascular Disease Risk as Determined by the Framingham Risk Score and Arterial Stiffness in a Health-Examined Population in China
por: Zhu, Wenfang, et al.
Publicado: (2022)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Associations of serum uric acid with cardiovascular disease risk factors: a retrospective cohort study in southeastern China
por: Luo, Yingxian, et al.
Publicado: (2023)

Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
por: Morace, Carmela, et al.
Publicado: (2023)

Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders
por: Upadhyay, Ravi Kant
Publicado: (2015)

Inflammatory Biomarkers and Risk of Atherosclerotic Cardiovascular Disease
por: Yu, En, et al.
Publicado: (2018)

Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: Abdelhak, A., et al.
Publicado: (2018)

Association of maternal TSH and neonatal metabolism: A large prospective cohort study in China
por: Hou, Qingzhi, et al.
Publicado: (2022)

Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma
por: Bai, Ju, et al.
Publicado: (2019)

Serum Gamma-Glutamyltransferase Levels are Associated with Cardiovascular Risk Factors in China: A Nationwide Population-Based Study
por: Li, Dan-Dan, et al.
Publicado: (2018)

Novel biomarkers for cardiovascular risk prediction
por: Wang, Juan, et al.
Publicado: (2017)

Association between serum 25(OH)D and risk of all-cause mortality in adults with prior cardiovascular disease: a cohort study from NHANES 2007–2018
por: Hu, Ben, et al.
Publicado: (2023)

Household Solid Fuel Use and Cardiovascular Disease in Rural Areas in Shanxi, China
por: QU, Weihua, et al.
Publicado: (2015)

Association of Serum Uric Acid with Cardiovascular Disease Risk Scores in Koreans
por: Lee, Seung Yun, et al.
Publicado: (2019)

The Association of Serum Immunoglobulins with Risk of Cardiovascular Disease and Mortality: the Rotterdam Study
por: Khan, Samer R., et al.
Publicado: (2023)

Association between cardiovascular disease- and inflammation-related serum biomarkers and poor lung function in elderly
por: Egervall, K., et al.
Publicado: (2021)

Hourly PWV Dataset Derived from GNSS Observations in China
por: Zhao, Qingzhi, et al.
Publicado: (2019)

Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers
por: Dumitru, Raluca B, et al.
Publicado: (2021)

Iodine Deficiency of Breastfeeding Mothers and Infants from 2012 to 2019 in Zhengzhou, China
por: Wang, Xinyi, et al.
Publicado: (2022)

Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer
por: Kamai, Takao, et al.
Publicado: (2018)

DNA Methylation as a Biomarker for Cardiovascular Disease Risk
por: Kim, Myungjin, et al.
Publicado: (2010)

Extracellular Vesicles as Biomarkers in Cardiovascular Disease; Chances and Risks
por: Dickhout, Annemiek, et al.
Publicado: (2018)

Serum Irisin as a Potential Biomarker for Cognitive Decline in Vascular Dementia
por: Zhang, Feng, et al.
Publicado: (2021)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2022)

Association between Acrylamide Metabolites and Cardiovascular Risk in Children With Early Stages of Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Biomarkers of Cardiovascular Disease
por: Huang, Ying, et al.
Publicado: (2017)

Lead Concentrations in Relation to Multiple Biomarkers of Cardiovascular Disease: The Normative Aging Study
por: Peters, Junenette L., et al.
Publicado: (2011)

Prediction of sarcopenia using a combination of multiple serum biomarkers
por: Kwak, Ju Yeon, et al.
Publicado: (2018)

Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
por: Panezai, Jeneen, et al.
Publicado: (2022)

Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: Abdelhak, A., et al.
Publicado: (2019)

Tamoxifen, serum lipoproteins and cardiovascular risk.
por: Bruning, P. F., et al.
Publicado: (1988)

Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment
por: Jigoranu, Raul-Alexandru, et al.
Publicado: (2023)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_htqslcn816knintco97c813aah